Penn Center for AIDS Research

Developmental Pilot Awards


The Penn CFAR Developmental Core Pilot Award Program is designed to assist faculty member applicants (Assistant Professor and above) and junior non-faculty applicants (Instructor and/or Research Associate) to launch or further develop a successful independently funded HIV/AIDS-related project. In addition to funding, this support is provided through mentoring (or collaborative partnerships for more seasoned investigators). All funded pilot award recipients are assigned CFAR program mentors for the duration of the project, but mentoring is available regardless of whether or not an application is funded. 



Please see the current Program Guidelines for complete eligibility information. If you have any questions about eligibility, please contact Developmental Core Director (Liz Lowenthal, MD MSCE;


Types of Awards

Successful CFAR Pilot Awards focus on any aspect of HIV/AIDS clinical care, epidemiology, virology, immunology, structural biology, vaccine development, or prevention that are determined to be relevant to the goals of our program. Priority is given to junior faculty who have no other source of funding and who are seeking support for the development of preliminary data for an NIH R01-type application.  The University of Pennsylvania CFAR Developmental Core offers two types of pilot awards:

General Pilot Awards: Faculty members

Eligible applicants must have a faculty appointment of at least Assistant Professor or its equivalent at a Penn CFAR institution. It is also acceptable to have an appointment by the award date.

For junior faculty applicants, a one-page mentorship plan with a senior faculty member is strongly encouraged; for non-HIV/AIDS investigators, a partnership plan with an established HIV/AIDS investigator is strongly encouraged. Contact the Developmental Core for assistance with identifying partnerships.

Mentored Research Scholar Awards: Young Investigators (Pre-Faculty)

Young investigators at the Instructor, Research Associate, Wistar Staff Scientist, or Wistar Research Assistant Professor level are eligible for mentored awards. Senior fellows will also be considered if they have institutional commitment for a pre-faculty position at the time the award will start. Applicants should be poised to begin an independent research program. If you have any questions about eligibility, please contact Developmental Core Director (Liz Lowenthal, MD MSCE;

Mentored Research Scholar Award applications must include a letter of support from their scientific mentor. For fellows, an institutional letter of support is also required. In addition to these letters, a one-page mentorship plan is required. Guidelines for the Mentorship Plan are available through the CFAR website.

If you have any questions about eligibility, please contact Developmental Core Director (Liz Lowenthal, MD MSCE;


Request for Applications

The Penn Center for AIDS Research (Penn CFAR) is not currently accepting applications for our pilot award program. Please stay tuned for our next funding opportunity, and see the Pilot Program Guidelines for more details.


Goals for All Participants

The Developmental Core is intended to help pilot grant applicants achieve the following goals:

  • Translate the pilot grant application into a subsequent competitive external funding application (i.e., NIH or other agency)
  • Gain familiarity with the Penn CFAR and CFAR Cores and services.
  • Network with local like-minded professionals. The Core provides opportunities to interact with colleagues in the Penn CFAR and can provide introductions to colleagues working throughout the University of Pennsylvania, The Wistar Institute, and the Children’s Hospital of Philadelphia. 
  • Identify potential opportunities for extramural collaboration.
  • Develop awareness of policies and procedures relevant to the awardee's work (e.g., clear understanding of human subjects and/or animal research requirements, international research guidelines, good clinical practice).
  • Achieve career advancement and work towards independence as HIV-focused researchers.
  • Establish an ethically sound research environment.
  • Assist applicants whose pilot submissions were not funded to address reviewers' concerns to achieve success in the following application cycle.


Responsibilities of the Awardee / Participant Applicant

In accepting the Pilot Grant, awardees agree to:

  1. Participate in the Pilot Program Charge meeting held at beginning of the grant year, following notice of award.
  2. Utilize resources of the CFAR to maximize their research success. The CFAR faculty’s time and the CFAR Developmental Core are valuable resources. It is the responsibility of the awardee/applicant to ask for assistance when needed and to be fully prepared for mentoring meetings. Preparatory materials such as an agenda, pending papers, drafts of future grant specific aims, or other information should be provided at least 2 weeks in advance of meetings.
  3. In presentations, abstracts, and publications, acknowledge CFAR funding with either of the following, as appropriate:
    • Direct CFAR Funding Support: This research was supported by a grant from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008).
    • Indirect/Partial Funding Support: This publication/presentation/grant proposal was made possible through core services and support from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008).
  4. The awardee/applicant must participate actively in the program relationship and engage the assigned CFAR faculty in the process of transforming the pilot award grant into a subsequent grant submission. The awardee/applicant should engage the mentor at all stages of grant preparation, from the initial conception of an idea to the final grant submission.
  5. The pilot awardee must provide the CFAR mentor with a copy of any grant application in a reasonable time (i.e., at least 4 weeks for NIH K- and R-series awards) for feedback. This timeline requires that mentorship start well before submission (i.e., at least 3 months prior to due date) to allow for revision and final critical review.
  6. To monitor progress of the Pilot project and submission of a subsequent grant application, the awardee must meet at least twice a year, more if indicated in the mentoring plan or as requested by his/her CFAR faculty mentor. Awardees/applicants agree to send a preparatory e-mail to the mentor outlining the topics to be covered and their goals for each mentoring meeting.
  7. The awardee/applicant should take advantage of opportunities for collaborative research within the Penn CFAR and other CFARs across the country.
  8. The awardee should participate in general professional development activities and research in-progress sessions, such as Pilot Feedback Talks, coordinated by the CFAR Development Core for added feedback on active awards.
  9. Awardees will complete the NIH Human Subjects Study Record required for all projects with a human subjects component. To determine if your project has a human subjects component, please see the NIH Questionnaire.  
  10. Mentees will complete annual progress reports that review progress, spending, highlights, next steps, and track abstracts/presentations/publications.
  11. The awardee will complete a survey distributed by the CFAR Developmental Core related to the mentorship program. This information should be factual and focus on scientific progress and a frank evaluation of the pilot program. The goal is to identify things that work and things that do not work so the program can be improved in subsequent years of this grant cycle. 


Recipients of Developmental Core Pilot Grants in HIV/AIDS

Fiscal Year Investigators Title of Project  
2024 Nancy Aitcheson, MD, MSHP PEP-talk: Designing Implementation Strategies for HIV Prevention at Plume  
2024 Rebecca Clark, PhD, RN Understanding how pregnant and postpartum women living with HIV make infant feeding choices and their perceptions of related clinician communication  
2024 Bonnie Ky, MD, MSCE Understanding Cardiovascular Risk in HIV and Breast Cancer in Botswana  


Luis Montaner, DVM, MSc, DPhil Immunopathogenesis of Monkeypox Infection in Virally-suppressed People Living With HIV  
2023 Florence Momplaisir, MD Contextual inquiry for the development of a social network strategy intervention to reduce racial inequities in monkeypox vaccination: an HIV status neutral approach  

David Allman, PhD

Engaging rare B cell precursors in HIV  

Amelia Escolano, PhD

Targeting premium antibody lineages to streamline anti HIV-1 bNAb development by vaccination  

Yeonsoo Baik, MPH, PhD

Diagnostic accuracy of GeneXpert Ultra testing for Mycobacterium Tuberculosis on oral swab samples in South Africa


Sally Chan, PhD & Dolores Albarracin, PhD - Joint Pilot, co-sponsored with PMHARC

Developing a Machine Learning Method to Increase HIV/HCV Prevention and Care and Substance Use Treatment in People Who Inject Drugs  

Benjamin Reiner, PhD & Matthew Hayes, PhD - Joint Pilot, co-sponsored with PMHARC

Characterization of rhesus macaque frontal cortex and basal ganglia cell type-specific transcriptomes in a post-SIV infection time course  

Matthew Schindler, PhD & Dennis Kolson, PhD - Joint Pilot, co-sponsored with PMHARC

Neuropsychiatric complications of COVID19 in HIV: a clinical and 7T MRI Pilot Study  

Rebecca Stewart, PhD & Margaret Lowenstein, PhD - Joint Pilot, co-sponsored with PMHARC

Mobile Service Delivery in Response to the Opioid and HIV Epidemics in Philadelphia  

Cedric Bien-Gund, MD

Peer Mentors to Expand HIV Self-Testing and PrEP/ART for Medically Disconnected MSM


Hansel Otero, MD

Brain Ultrasound in the Evaluation of Early Neurodevelopmental Differences between HIV-exposed Uninfected and HIV- unexposed Uninfected Newborns and Infants


Aaron Richterman, MD, MPH

Mental Bandwidth in Pregnant Women with HIV

2022 Cagla Akay-Espinoza, MD HIV viral dynamics and host-cell gene expression profiles in human induced pluripotent stem cell derived myeloid cells  
2022 David Hill, MD, PhD Influence of HIV/ART on Adipose Tissue Myeloid Suppressor Cells  
2022 Sarita Sonalkar, MD Development of an implementation strategy to integrate HIV pre-exposure prophylaxis into family planning care  
2022 Elizabeth White, PhD HPV Oncogene Diversity and lnflammation in HIV- and HIV+ Cancers  
2022 Nancy Aitcheson, MD -  Joint Pilot, co-sponsored with LDI Implementation of Routine, Opt-out HIV Screening in Emergency Departments in West Philadelphia:  Building on Success  
2022 Stephen Bonett, PhD, RN -  Joint Pilot, co-sponsored with LDI Evaluating the implementation of low-threshold PrEP services in sexual wellness clinics  
2022 Rebecca Stewart, PhD -  Joint Pilot, co-sponsored with LDI Feasibility and Acceptability of Harm Reduction Vending Machines in Philadelphia  
2022 Daniel Teixeira da Silva, MD -  Joint Pilot, co-sponsored with LDI Enhancing HIV testing and PrEP Delivery in Substance Use Disorder Treatment Programs  
2022 Jennifer McGuire, MD, MSCE - Joint Pilot, co-sponsored with PMHARC Immune dysregulation and neurodegeneration in adolescent SIV infection: radiographic and neuropathologic correlates  
2022 Yijing Su, PhD. - Joint Pilot, co-sponsored with PMHARC Identification of molecular signature of HIV infected cells in CNS using single cell multi-omics technology  
2021 Florence Momplaisir, MD, MSHP Acceptability and feasibility of MAT and mobile application to support PrEP adherence in women with opioid use disorder  
2021 Katharine Rendle, PhDh, MSW, MPH Improving timeliness of cervical cancer care in women living with HIV in Botswana  
2021 Ian Tietjen, PhD Assessing "Mukungulu" as a novel, natural HIV latency reversal agent  
2021 Jessie Torgersen, MD, MHS, MSCE Evaluation of the validity of an automated electronic program to identify hepatic steatosis in HIV infected and uninfected patients within non-contrast abdominal CT scans  
2020 Simon Lacey, PhD -  Joint Pilot, co-sponsored with the Abramson Cancer Center Development of Gamma-Delta T cells with CRISPR Knock-In of CAR19 into CCR5 Gene (gamma delta CAR19-CCR5KO) as a Therapy for HIV-Associated B cell Lymphomas  
2020 Susan Coffin, M.D., MPH Characterizing the Epidemiology and the Microbiology of Sepsis in HIV-exposed Neonates in Gaborone,  Botswana  
2020 Kyle Kampman, M.D. Long-acting buprenorphine for high-risk opiate use disorder individuals  
2020 Daniel Kulp, Ph.D. DNA-launched nanoparticle vaccine design  
2020 Florence Momplaisir, M.D., MSHP Assessing attitudes, beliefs, and interest for pre-exposure prophylaxis (PrEP) in pregnancy and in the postpartum period  
2020 Hamideh Parhiz, PharmD, Ph.D. Targeted Delivery of engineered recombinase-encoding mRNA lipid nanoparticles for eradication of HIV  
2020 Chamith Rajapakse, Ph.D. Comprehensive MRI of the Hip in HCV and HIV/HCV Coinfected Patients  
2019 Yehoda Martei, M.D. MSCE Impact of Toxicity on Therapy Delivery and Outcomes in HIV-Infected Breast Cancer Patients  
2019 Mohamed Abdel-Mohsen, PhD - Joint Pilot, co-sponsored with the Microbiome Program Deciphering the Interactions Between Gut-associated Glycome and Microbiota During HIV Infection  
2019 Merrian Brooks, DO, MS  - Joint Pilot, co-sponsored with the Penn Mental Health AIDS Research Center  Expanding an Adapted Friendship Bench Near Peer Lay Counselor Intervention Pilot to Explore Mental Illness and Co-Occurring Substance Use/Abuse in Youth at Risk for and Living with HIV  
2019 Aletha Akers, M.D. Understanding HIV Testing Behavior Among Young, Urban, At-Risk Women Seeking Contraceptive Services  
2019 Lily Brown, Ph.D. PTSD, Substance Use, Sleep Disorders, and Suicide Risk in Persons Living With HIV  
2019 Robert Carpick, Ph.D. Characterization of Hydrogels as Lubricious Coatings for Intrarectal Products  
2019 Sarita Sonalkar, M.D., M.P.H. Integration of HIV Pre-Exposure Prophylaxis Screen into Care for Women with Abnormal and Undesired Pregnancies  
2019 Jianxin You, Ph.D. Discovering the Immune Evasion Mechanism of Merkel Cell Carcinoma, an HIV-associated Malignancy  
2018 Mohamed Abdel-Mohsen, Ph.D. Cell-surface Glycomic Signature Associated with Blood and Tissue HIV Reservoirs  
2018 David Allman, Ph.D. Sequential immunization and lasting humoral immunity  
2018 Laurence Eisenlohr, VMD, Ph.D. Processing of HIV-1 antigens for MHC class-II restricted presentation  
2018 Shruthi Ravimohan, Ph.D. Host genetic correlates of aberrant immune recovery and pulmonary dysfunction in HIV/TB patients initiating ART  
2018 Oriol Sunyer, Ph.D. Using an evolutionary old immune system for the discovery of broadly neutralizing HIV-1 epitopes  
2018 Sarah Tishkoff, Ph.D. Impact of maternal exposure to HIV and anti-retroviral therapy on DNA methylation state in HIV-uninfected newborns in Botswana: A pilot study  
2017 C. Neill Epperson, MD - Joint Pilot, co-sponsored with ITMAT and the Chronobiology Program Impact of Circadian Phase and Insomnia on Risk for Early Cognitive Decline Among HIV-Infected Males and Females  
2017 Stewart Anderson, M.D. A model system for the study of human macrophage synaptophagy of human forebrain synapses in HIV  
2017 Surbhi Grover, M.D., M.P.H. Treatment Outcomes in HIV Patients with Locally Advanced Breast Cancer Who Receive Pre-Operative Chemotherapy  
2017 Michelle Johnson, Ph.D. Robot Assisted Rehabilitation After HIV-Associated Stroke  
2017 Laura Vella, M.D., Ph.D. Circulating T Follicular Helper Subsets as a Periscope into the Lymph Node and a Biomarker of HIV Resevoir  
2017 Sarah Wood, M.D. Social Support as Facilitator of Adherence to HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men  
2016 Carsten Skarke, PhD - Joint Pilot, co-sponsored with ITMAT and the Chronobiology Program Mapping the Human HIV Chronobiome  
2016 Emile Mohler, M.D. Evaluation of cardiovascular risk in patients infected with HIV  
2016 Courtney Schreiber, M.D., M.P.H. Contraceptive service delivery with a cervical cancer prevention program in Botswana: a hybrid type 2 clinical intervention and implementation strategy  
2016 Anastasios Vourekas, Ph.D. The role of RNA helicase DDX3X in the activation of HIV replication in latently infected T cells  
2016 AT Charlie Johnson, Ph.D. Graphene-Aptamer Biosensor to Detect Tenofovir in Urine  
2016 Chelsea Morroni, Ph.D., M.P.H. SACHOICE Study: Southern African Contraception and HIV Study: Options for Implant Continuation on Efavirenz  
2016 Changchun Liu, Ph.D., M.S. A Novel Point-of-Care Isothermal PCR Assay for Meningitis Diagnosis in Low Resource Settings  
2015 Nadia Dowshen, M.D. (Pediatrics) Development of a novel Mhealth intervention to improve adherence to antiretrovial therapy among HIV+ youth  
2015 Joseph Jarvis, M.D. (Medicine/ID); Madisa Mine, Ph.D. (Ministry of Health, Botswana Government) The feasibility and potential utility of cryptococcal antigen screening to reduce early mortality in patients initiating Antiretrovial Therapy in BOTS: a pilot study  
2015 Michael Mullen, M.D., MSCE (Neurology); David Bearden, M.D., (Neurology at CHOP) HIV and stroke in Botswana  
2015 Laura Su, M.D., Ph.D., (Medicine/Rheumatology) Characterizing influenza-specific follicular helper CD4+ T cells in the lymph nodes of HIV patients on anti-retrovial therapy  
2015 Anne Teitelman, PhD, FNP-BC, FAANP, FAAN (School of Nursing); Yukiko Washio, Ph.D. (TRI) What is the impact of substance use and violence on HIV testing among postpartum women?  
2015 Ramin Herati, Ph.D. (Microbiology; E. John Wherry, Ph.D. (Microbiology) Assessment of serological and cellular inflammation to predict influenza vaccine responses in HIV-infected individuals  
2014 Malitta Engstrom, Ph.D., LCSW (School of Social Policy & Practice) Community reinforcement and family therapy with men leaving prison and their female partners  
2014 David Issadore, Ph.D (Bioengineering), Gregory Bisson, M.D. (Medicine) The ultra-sensitive detection of rare mycobacterium tuberculosis using a µHall chip  
2014 Helen Koenig, M.D., MPH. (Medicine, ID), Karam Mounzer, M.D. (Medicine) Validation of a urine assay for the measurement of tenofovir levels as a means of monitoring adherence to truvada given as pre-exposure prophylaxis for HIV prevention  
2014 Emilio Parrado, Ph.D. (Sociology), Felicia Lewis, M.D., CDR, USPHS (Philadelphia Dept of Health) HIV risks and health care access among Mexican and Central American immigrants in Philadelphia  
2014 Xiaolu Yang, Ph.D. (Cancer Biology), Jim Riley, Ph.D. (Microbiology) Restriction of HIV by TRIM5a: mechanism and potential therapeutic application  



Abass Alavi, M.D. (Radiology), Pablo Tebas, M.D. (Medicine/ID) Assessment of cardiovascular and central nervous system complications of HIV/AIDS by PET/CT imaging  
2013 Katharine Bar, M.D. (Medicine/ID) Viral Dynamics of HIV-1 Rebound Viremia  
2013 Henry Kranzler, M.D. (Psychiatry), David Metzger, Ph.D. (Psychiatry) Cognition as a Potential Mediator of Alcohol Use and Poor ART Adherence in HIV+ Drinkers  
2013 Lilie Lin, M.D. (Radiation Oncology), Surbhi Grover (Medicine), Doreen-Ramogola-Masire (Botswana-UPenn) Impact of HIV infection and treatment on tolerability of cervical cancer therapy  
2013 Deirdre Sawinski, M.D. (Medicine/ Renal), and Emily Blumberg M.D. (Medicine) Effect of rATG on HIV reservoirs in HIV+ kidney transplant recipients  
2013 Jean Scholz, Ph.D. (Pathology & Lab Med), Michael Cancro (Pathology & Lab Med) Are potentially broadly neutralizing clonotypes eliminated at peripheral selection checkpoints?  
2012 David Artis, Ph.D. (Microbiology), Gregory Sonnenberg, Ph.D. (Microbiology) Immune regulation of intestinal barrier function following SIV infection  
2012 Paul Bates, Ph.D. (Microbiology) NFkB activation by Tetherin  
2012 Haim H. Bau, Ph.D. (Engineering), Changchun Liu, Ph.D. (Engineering), and Robert Gross, M.D., M.S.C.E. (Medicine/ID; CCEB) Point of Care, Integrated System for Molecular Detection of HIV  
2012 Hans-Peter Kohler, Ph.D. (Sociology) and Iliana Kohler, Ph.D. (PSC) Mental Health, HIV and Aging in a poor high-risk disease environment: A pilot study in rural Malawi  
2011 Jennifer Cohn, M.D. (Medicine/ID) Mobile telecommunication solutions to improve HIV patient care at the community level in Kenya  
2011 Ron Collman, M.D. (Med/Pulmonary) and Anjana Yadav, Ph.D. (Medicine); Dennis Kolson, M.D., Ph.D. (Neurology) Stain modulation of monocyte activation: a pilot study for potential use in NeuroAIDS  
2011 Dennis Dlugos, M.D., M.S.C.E (Neurology at CHOP) and David Bearden, M.D. (Neurology at CHOP) Risk Factors for Seizures in Children with HIV/AIDS in Botswana  
2011 David Metzger, Ph.D. (Psychiatry) and Sumedha Chhatre, Ph.D. (Psychiatry) Effects of stress reduction on chronic immune activation and inflammation  
2011 Shikata Mudakha, M.D. (Medicine/ID) and Mary Kestler, M.D. (Medicine/ID); Harvey Friedman, M.D. (Medicine/ID) Developing a TB screening algorithm for coughers presenting for inpatient care in an arear of high HIV prevalence  
2011 Virginia Stallings, M.D. (Pediatrics, CHOP) Botswana Vitamin D Supplementation Study in HIV/AIDS  
2010 Sita Awasthi, Ph.D. (Medicine/ID) To establish a humanized mouse model for HSV-2 and HIV-1 Co-infection  
2010 Ron Collman, M.D., (Med/Pulmonary) and Nicola Zetola, M.D. (Botswana) Alcoholism and MDR TB in HIV patients in Botswana  
2010 Andrea Doyle, Ph.D. (Social Policy & Practice) and Jeffrey Draine, Ph.D., (Social Policy & Practice) Healthcare engagement of women who test positive for HIV in a vaccine trial  
2010 Robert Gross, M.D., MSCE (Medicine) and Elizabeth Lowenthal, M.D. Psychosocial Assessments of HIV-infected children and adolescents in Botswana  
2010 Carrie Kovarik, M.D. (Dermatology) and Rahat Azfar, M.D. The use of mobile telemedicine for remote diagnosis of HIV-infected patients in Botswana  
2010 Daniel Langleben, M.D. (Psychiatry) and Daniel Romer, Ph.D. (Annenberg) Functional MRI of Brain Response to HIV Prevention Public Service Announcements  
2010 Vincent Lo Re, M.D., (Medicine, ID) and Mary Leonard, M.D., MSCE A structural approach to bone disease due to Hepatitis C co-infection in HIV  
2010 Zhengyu Ma (CHOP) and Dennis Discher, Ph.D. (Engineering) Probing the mechanism of HIV TCR specificity using atomic force microscopy  
2010 Jon Merz, J.D., Ph.D. (Medical Ethics) and Francis Barchi, M.S. Botswana Ethics Training Initiative: Using web-based tools to enhance learning and skills-development in research ethics training of host-country HIV/AIDS  
2010 Andrew Steenhoff, M.D. (Pediatrics) and Nicola Zetola, M.D. Novel diagnostics for pediatric tuberculosis  
2009 Stefania Gallucci, M.D.(Pediatrics), and David Weiner, Ph.D. (Path/Lab Medicine) Clonogenic Progenitors of Dendritic Cells as Novel Antigen Carrier in anti-HIV  
2009 Toorjo Ghose, M.S.W., Ph.D. (Social Policy & Practice) Implementing PATH-India: Reducing HIV Risk Among the Dually Diagnosed in India  
2009 John Kempen, M.D, M.H.S., M.P.H., Ph.D. (Opthalmology), and Maureen Maguire, Ph.D. (Opthalmology) Pilot Study in Preparation for the Intravitreous Ganciclovir-Valganciclovir Cytomegalovirus Retinitis Trial (GIVCyT)  
2009 Steven Marcus, Ph.D. (Social Policy & Practice), and Julie Cederbaum, M.S.W.,M.P.H. (Social Policy & Practice) HIV Serostatus and its Influence on Mother Influence Behaviors and Adolescent Engagement in HIV Risk Behaviors  
2009 Doreen Ramogola, M.D. (Women's Health, University of Botswana), and Harvey Friedman, M.D. (Medicine, ID) Epidemiology of HPV Infection in HIV-infected Women with Precancerous Cervical Lesions in Botswana  
2009 Samir Shah, M.D., M.S.C.E.. (Pediatrics, Epidemiology), and Zsofia Szep, M.D. (Medicine, ID) Association of Serum Vitamin D Levels and Insulin Resistance Among Patients Infected w/Human Immunodeficiency Virus  
2008 Frederic Bushman, Ph.D. (Microbiology) The Macaque Gut Microbiota and SIV Infection  
2008 Branch Coslett, M.D. (Neurology) and Kathy Lawler, M.D. (Neurology) Assessment of HIV-Related Dementia and Depression in Botswana  
2008 Roy Kim, M.D. (Pediatrics) and Ian Frank, M.D. (Medicine, ID) Effects of Recombinant IGF-I in HIV-Associated Metabolic Disease  
2008 Susan Ross, Ph.D. (Microbiology) Development of an in vivo Model to Study APOBEC3G/vif Interaction  
2008 Courtney Schreiber, M.D. (OB/GYN) How to Avoid Pregnancies in HIV Prevention Trials: a Case-Control Study and Point-of-Care Questionnaire  
2008 Anne Teitelman, Ph.D. (Nursing); Loretta Sweet Jemmott, Ph.D. (Nursing); Therese S. Richmond, Ph.D. (Nursing); and William Holmes, M.D. (Medicine/Epidemiology) HIV/STI Risk Reduction for African-American Adolescent Girls: Addressing the Context of Partner Abuse  
2007 John B. Jemmott, III, Ph.D. (Psychiatry) and G. Anita Heeren, M.D., MSc., Ph.D. (Annenberg School of Communication) HIV/STI Risk Reduction for African American Men  
2007 Shane T. Jensen (Statistics, Wharton) and Jon D. McAuliffe (Statistics, Wharton) Spatially Varying Evolutionary Models of Viral Escape Response  
2007 Dennis Kolson, M.D., Ph.D. (Neurology) and Julio Martin-Garcia, Ph.D. (Microbiology/Immunology, Drexel) Neurotropism and Neurovirulence of Subtype C HIV-1 Isolates from Botswana  
2007 Ian C. MacMillan, MBA, DBA (Wharton); Darren Linkin, M.D. (Medicine, ID); James Thompson, MBA, Ph.D. (Wharton); Alan Abrahams, Ph.D. (Wharton); Diana Dickenson, M.D. (Clinician in Gaborone, Botswana); and Peter Ehrenkranz, M.D., MPH (Clinical Scholars, Penn) A Pilot Study of Cellular Phone Text Message Reminders to Improve HIV Medication Adherence in the Developing World  
2007 Erle Robertson, Ph.D. (Microbiology) and Gregory Bisson, M.D., M.S.C.E. (Medicine, ID) Identification of an Etiological Basis Associated with Ocular Surface Squamous Neoplasia  
2007 Guido Silvestri, M.D. (Pathology and Laboratory Medicine) and Ian Frank, M.D. (Medicine, ID) Mucosal Immune Activation in HIV-infected Patients  
2006 Yair Argon, Ph.D. (Pathology and Laboratory Medicine) and Stefania Gallucci, M.D. (Pediatrics, Children’s Hospital) Augmenting the Presentation of HIV Peptides to T cells using an Engineered Chaperone Protein  
2006 Michael Betts, Ph.D. (Microbiology) and Ian Frank, M.D. (Medicine, ID) Modulation of HIV-specific CD8+ T cell Function and Control of HIV Replication During and After Cessation of HAART  
2006 Arthur Caplan, Ph.D. (Medicine, Medical Ethics) An Ethical Framework for HIV Vaccine Research  
2006 Sridhar Hannenhalli, Ph.D. (Genetics) and Frederic Bushman, Ph.D. (Microbiology) Computational Analysis of HIV-1 Integration in the Human Genome  
2006 Nancy Hanrahan, Ph.D. (School of Nursing) Quantifying Nurse Interventions in the Treatment of Individuals with Serious Mental Illness and HIV  
2005 Randy Cron (Pediatrics, Children’s Hospital) and Pablo Tebas (Penn Medicine, ID) NFAT Activity in CsA-Treated HIV-1-Infected Individuals  
2005 Stefania Gallucci (Pediatrics, Children’s Hospital) and Terri Finkel (Pediatrics, Children’s Hospital) Activating Anti-HIV Dendritic Cells by Abnormal Cell Death  
2005 Edward George (Statistics, Wharton) Exploratory Markov Modeling of Discrete Biomarkers  
2005 David Oslin (Medicine, Psychiatry) Aging Among HIV-infected Individuals as a Risk for Cognitive Decline and Poor Adherence  
2005 Pablo Tebas (Medicine, ID) Prevalence of HCV and HBV Among HIV Positive Patients in the Dominican Republic  
2004 Harvey Friedman (Medicine, ID) and Gregory Bisson (Medicine, ID) Virologic Effectiveness, Predictors of Virologic Failure and Development of a Clinical Prediction Rule for Virologic Success in the Botswana National ARV Program  
2004 John Detre (Neurology) and Beau Ances (Neurology) Brain Activation Using fMRI in Asymptomatic, Mild Cognitive Motor Deficit, and AIDS Dementia Patients  
2004 Muredach P. Reilly (Medicine, Cardiovascular Division) Pilot Study of the Genetics of ART-associated Dyslipidemia in HIV  
2004 Hao Shen (Microbiology) Role of CD4 Help in Heterologous Prime-Boost Immunization  
2003 Li-Wei Chao (Anesthesiology, Children’s Hospital) and Mark Pauly (Wharton) Educator and Pupil Training in HIV/AIDS in South Africa  
2003 Andrew Dancis (Medicine, Hematology/Oncology) Roles for Three Distinct Iron Uptake Systems in Mucosal Infections by Candida albians  
2003 Paul Lieberman (The Wistar Institute) Regulation of Kaposi's Sarcoma-Associated Virus Reactivation  
2003 Gerd Maul (The Wistar Institute) Improvement for Gag DNA Vaccine Vector by Nuclear Targeting  
2003 Barbara Turner (Medicine) and Kathleen Brady (Medicine) Unlinked Seroprevalence Testing of Hepatitis C in Inpatients  
2002 Jean Boyer (Pathology and Laboratory Medicine) A Polarized Th2 Immune Response Can Decrease HIV-1 Vaccine Efficacy  
2002 Robert Doms (Microbiology) Analysis of Envs from HIV-infected Children in Nairobi, Kenya  
2002 J. Kevin Foskett (Physiology) Interaction of HIV Nef with the Inositol Trisphophate Receptor Intracellular Ca2 Release Channel  
2002 Kaivan Munshi (Economics, School of Arts and Sciences) Marriage and Sexual Behavior: With an Application to Urban Migrants in Kisumu, Kenya  
2002 James Riley (Pathology and Laboratory Medicine) Control of CCR5 Expression in Primary CD4 T Cells  
2001 Michael Blank (Psychiatry) and Aileen Rothbard (Psychiatry) Co-Occurrence of HIV/AIDS Among Persons with Severe Mental Illness  
2001 Bruce Freedman (Animal Biology, School of Veterinary Medicine) Mechanism of HIV-1 gp120 Induced Capping on Primary Human Macrophages  
2001 Samuel Parry (Ctr for Research on Reproduction and Women’s Health) Transmission of Human Immunodeficiency Virus Across the Placenta  
2001 William Swiggard (Medicine, ID) Interactions of Circulating Human Dendritic Cells with HIV-1  
2000 Jeffrey Field (Pharmacology) Role of Pak kinases in Kaposi's Sarcoma  
2000 Stuart Isaacs (Medicine, ID) Development of Novel Recombinant Vaccinia Virus Based anti-HIV Vaccines  
2000 Robert Ricciardi (Microbiology, School of Dental Medicine) A Novel Approach for Identifying HHV-8 Anti-virals  
2000 Antonia Villarruel (School of Nursing) Effectiveness of an HIV Risk Reduction Intervention for Spanish-speaking Latino Youth  
2000 Susan Watkins (Sociology) and Jere Behrman (Economics) Social Science Aspects of Intergenerational and Intragenerational Interactions Related to HIV/AIDS in a High HIV/AIDS Incidence sub-Saharan Population  

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Report Accessibility Issues and Get Help | Privacy Policy | Site Design: DART Web Team.